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Mutilating palmoplantar keratoderma represents a
heterogeneous group of disorders, unified by character-
istic mutilation of the fingers or toes, associated with
palmoplantar keratoderma. Although loricrin gene
mutations were recently reported in Vohwinkel’s syn-
drome and erythrokeratoderma, the genetic basis of
mutilating palmoplantar keratoderma is largely unex-
plored. We studied a family of non-Vohwinkel’s syn-
drome, nonerythrokeratoderma mutilating palmoplantar
keratoderma. The proband and his sister were similarly
affected. Recessive inheritance was expected from the
consanguineous family history. The patients had hyper-
keratosis restricted to the palms and the soles. No other
body sites were affected. Digital constriction was seen
on all the fingers and the mutilation was severe on the
distal interphalangeal region of several fingers. Histo-
pathologically, hyperkeratosis without parakeratosis was
seen in the lesional skin. Ultrastructural, immunohisto-
One of the striking events during the process of theterminal differentiation in stratified squamous epitheliasuch as the epidermis is the formation of a 15 nmthick layer of protein on the inner surface of the cellperiphery, termed the cornified cell envelope (CCE)
(Hohl, 1990; Greenberg et al, 1991; Reichert et al, 1993). The CCE
is now known to be assembled by the accumulation of several distinct
proteins, including involucrin (Rice and Green, 1979; Eckert et al,
1993), cystatin a (previously known as keratolinin) (Zettergren et al,
1984; Kartasova et al, 1987; Takahashi et al, 1992), several small proline-
rich proteins (SPRP) (Kartasova et al, 1987; Backendorf and Hohl,
1992; Gibbs et al, 1993), trichohyalin (Lee et al, 1993), loricrin (Mehrel
et al, 1990; Hohl et al, 1991; Yoneda et al, 1992; Yoneda and Steinert,
1993), and possibly filaggrin (Richards et al, 1988; Steven and Steinert,
1994) and keratin intermediate filaments (Abernethy et al, 1977; Steven
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chemical, and immunoelectron microscopic analyses
revealed malformed cornified cell envelopes, the
abnormal intracytoplasmic loricrin retention, and
reduced deposition of loricrin to cornified cell envelopes.
Involucrin and small proline-rich proteins 1 and 2 were
normally distributed. Sequencing of the entire exons and
exon-intron borders of loricrin gene of the patients
excluded a mutation in loricrin DNA sequence. Linkage
analysis excluded the possibility of causative mutation in
the epidermal differentiation complex region of 1q21,
including loricrin, involucrin, small proline-rich proteins,
filaggrin, and trichohyalin. These data confirm the pres-
ence of non-Vohwinkel’s syndrome mutilating palmo-
plantar keratoderma phenotype with abnormal loricrin
cross-linking at the final stage of cornified cell envelope
formation, which is caused by mutations outside the
epidermal differentiation complex region. Key words:
genodermatosis/keratinization/loricrin/mutilation. J Invest
Dermatol 111:133–138, 1998
and Steinert, 1994). Among these molecules, loricrin is one of the
major precursor proteins of CCE (Steinert and Marekov, 1995).
A clinically and genetically heterogeneous group of disorders, known
collectively as the palmoplantar keratodermas (PPK), are unified by
the phenotypic characteristic thickening of the skin over the palms
and soles (Stevens et al, 1996). Although spectacular progress has been
made in the molecular basis of inherited disorders of the skin in recent
years, the genetic defects underlying the PPK are still largely unknown.
Epidermolytic PPK is caused by mutations in keratin 9 (Fuchs and
Green, 1980; Bonifas et al, 1994; Rothnagel et al, 1995; Navsaria et al,
1995), which is expressed exclusively in the skin of palms and
soles. In contrast, less is known about the molecular pathology of
nonepidermolytic PPK. There have been reports of linkage of the
diffuse nonepidermolytic PPK to keratin gene clusters on both chromo-
some 17q (Rogaev et al, 1993) and chromosome 12q (Lind et al, 1994)
and a mutation in the V1 domain of keratin 1 was also reported in a
diffuse nonepidermolytic PPK (Kimonis et al, 1994). Keratin 16
mutations have been reported in focal nonepidermolytic PPK (Shamsher
et al, 1995), and mutations in keratin 6, 16, and 17 in the related
disorder, pachyonychia congenita (Bowden et al, 1995; McLean et al,
1995). There has only been one report of linkage of a PPK, which
maps to chromosome 18q near the desmosomal cadherin gene cluster
(Hennies et al, 1995). In spite of these reports, we cannot exclude
possible candidate molecules for other phenotypes of PPK (Magro
et al, 1997).
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Recently, loricrin gene mutations were reported as causative defects
in two distinct types of PPK, Vohwinkel’s syndrome (VS) associated
with ichthyosis (Maestrini et al, 1996; Korge et al, 1997) and erythro-
keratoderma (EK) (Ishida-Yamamoto et al, 1997). Mutilation of the
fingers is a characteristic clinical feature shared by these two types of
PPK. In this context, one can predict that other forms of PPK with
mutilation might be due to alterations in CCE formation. These facts
stimulated us to study CCE formation, especially loricrin, in a family
of non-VS, non-EK mutilating PPK (MPPK) in order to elucidate
whether a loricrin abnormality is a common cause of mutilating
phenotype of PPK. The present ultrastructural, immunofluorescent,
and immunoelectron microscopic observations and DNA analysis
suggest that abnormal loricrin cross-linking in the formation of CCE
also underlies the phenotype of non-VS, non-EK MPPK in which
loricrin gene mutations are absent.
MATERIALS AND METHODS
Cases The proband, also referred to as case 1, was a 38 y old male of Japanese
origin, who was the first child of consanguineous parents (Fig 1a). His maternal
grandmother and paternal grandmother are sisters. His sister (case 2) was
similarly affected with MPPK. There is no other patient with MPPK in the
Figure 1. Linkage to the EDC on 1q21 is excluded in this family of
MPPK. (a) Pedigree of the family. Case 1 is the proband. Note the consanguinity
in the grandparents. (b) Analysis of microsatellite markers shows exclusion of
linkage to the three microsatellites, D1S2344, D1S2345, and D1S305, in case
1 and case 2. Note that the proband and his sister have inherited different
parental alleles for each of the three markers.
Figure 2. Characteristic clinical features and
histopathology of the finger lesion of the
proband. (a) The palm has a hyperkeratotic
waxy appearance. Marked pseudoainhum is
noted on the DIP joint of the right fourth
and fifth and left third fingers. (b) Marked
hyperkeratosis and moderate acanthosis are
seen (hematoxylin and eosin stain).
Hypergranulosis is present but parakeratosis is
not seen. Scale bar, 100 µm.
family as far as we know. Case 1 presented with palmoplantar keratotic lesions
that developed from his infancy (Fig 2a), gradually progressed, and became
stable in adolescence. He had no other skin abnormalities. His hair, teeth, and
nails appeared normal. His hearing was normal and he had no other congenital
anomalies. His palms and soles were hyperkeratotic and had a waxy appearance.
Pseudoainhum was noted on the joints of his right fourth and fifth and left
third fingers, and mild constrictions were rotated on the joints of other fingers
(Fig 2a). Surgical excision of the constricted fourth finger and skin graft on
the DIP joint of the right middle finger was carried out about 10 y ago. Skin
biopsies were obtained from an involved, constricted area of the second finger
and an uninvolved area of the forearm area under local anesthesia after informed
consent, and were processed for conventional light and electron microscopy,
immunohistology, and immunoelectron microscopy.
Case 2, the 33 y old sister of the proband, had very similar lesions to case 1.
She displayed well demarcated hyperkeratosis on the palms and the soles with
constrictions on the DIP joints of the fingers. Her hair, teeth, and nails appeared
normal. Her hearing was normal as well.
Antibodies The primary antibodies to CCE precursor proteins used in this
study were rabbit polyclonal anti-human involucrin antibody (Biomedical
Technologies, Stoughton, MA), mouse monoclonal anti-human SPRP 1 and
2 antibody (Kim et al, 1995), and rabbit polyclonal anti-human loricrin antibody
(Mehrel et al, 1990).
Immunofluorescent labeling Six micrometer thick sections of fresh skin
cut by cryostat were used as substrate. The sections were incubated in normal
horse and goat sera for 30 min, and then incubated in primary antibody solution
for 1 h at 37°C, followed by fluorescein isothiocyanate-conjugated to horse
anti-mouse IgG and IgM (Vector Laboratories, Burlingame, CA) for 30 min at
room temperature. Sections were extensively washed with phosphate-buffered
saline between incubations. Counterstaining was done by incubating the sections
in 10 µg propidium iodide per ml (to demonstrate nuclei) (Sigma, St.
Louis, MO) for 10 s. Stained sections were mounted with a cover slip in
mounting medium.
Post-embedding immunoelectron microscopy using cryofixation and
cryosubstitution without chemical fixative Post-embedding immuno-
electron microscopy using cryofixed and cryosubstituted skin specimens was
carried out as described previously (Shimizu et al, 1989) with slight modification.
Briefly, skin specimens were cryofixed by plunging them into liquid propane
cooled to –190°C, followed by cryosubstitution; they were then embedded in
Lowicryl K11 M (Chemische Werke Lowi, Waldkraiburg, Germany) at –60°C.
The specimens were polymerized by ultraviolet irradiation. Ultrathin sections
were incubated for 2 h at 37°C with a primary antibody. After being washed,
each section was placed on a drop of 1 nm gold-labeled goat anti-mouse or
rabbit IgG (Amersham International, Buckinghamshire, U.K.) diluted 1:40 at
room temperature for 2 h, and was then washed with distilled water. For easier
observation, the 1 nm gold particles were enlarged by incubation with
immunogold silver-enhancement solution (Amersham International) at room
temperature for 6 min (for observation at high magnification) or 10 min (for
observation at low magnification) (Shimizu et al, 1992). The sections were
counterstained with saturated uranyl acetate and lead citrate for 6 and 2 min,
respectively.
Direct sequencing of the loricrin gene DNA was isolated from peripheral
blood leukocytes of the proband (case 1), his sister (case 2), and their parents.
The entire coding sequence of the loricrin gene was polymerase chain reaction
(PCR) amplified from genomic DNA using the kit Expand Long Template
PCR System with High Fidelity Taq (Boehringer, Mannheim, Germany),
which alleviated the problems due to very high G-C content of the sequence.
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Figure 3. Electron microscopy of the
lesional skin of the proband shows
abnormal CCE formation. Granular cells
have normal keratin bundles and keratohyalin
granules (a). Thin CCE is normally formed
in the granular cells (b), but in the cornified
cells, CCE in patient skin (c) is remarkably
thinner than in normal control skin (d). Ring-
shaped structures of thin CCE and desmo-
somes are seen in an upper granular cell (e).
Arrowheads, CCE; arrows, lipid droplets. Scale
bars, (a) 2 µm, (b–d) 0.2 µm, (e) 0.5 µm.
The primers used to amplify exon 1 of loricrin were 59-GTTTGACTCT-
CTTAGGGCAC-39 (forward) and 59-GTCAGGCCTGGGCAAGACCA-39
(reverse), derived from GenBank file M94077, and PCR was carried out at
95°C for 5 min, then 40 cycles of 95°C for 1 min, 55°C for 1 min, and 72°C
for 2 min. The primers used to amplify exon 2, designed from the published
sequence (GenBank M94077), were 59-GCTGAGGCTCTGGCACCTG-
AAAG-39 (forward) and 59-GCCGGAGAGCTCAATGGCTTCT-39 (reverse),
producing a PCR product of 1235 bp. PCR conditions were: 5 min at 95°C,
then 1 min at 95°C, 45 s at 65°C, and 2 min at 72°C for 35 cycles. PCR
products were verified on agarose gel, purified using the Centriflex Gel Filtration
Column from ACGT, and directly sequenced, using the ABI PRISM Dye
Terminator Cycle Sequencing Kit with AmpliTaq DNA Polymerase, FS (Perkin
Elmer-ABI, Foster City, CA). The sequences were run on an ABI 310 Prism
Sequencer (Applied Biosystems, Foster City, CA).
Linkage analysis Microsatellite markers used for exclusion of the epidermal
differentiation complex (EDC) region were part of the U.K. MRC Human
Genome Mapping set (Reed et al, 1994). PCR reactions were performed using
primers end-labeled with [γ33P]dATP and PCR was carried out according to the
following program: 95°C for 5 min, followed by 27 cycles of 95°C for 1 min,
55°C for 1 min, 72°C for 1 min, and electrophoresis on a 6% acrylamide gel
followed by autoradiography. Genotypers were assigned by visual inspection. The
marker map used was D1S534–1.0-D1S422–2.2-AFM135yc3–0.1-D1S2345–
3.0-D1S2346–1.0-AFMa357ze5–0.1-D1S305–5.4-SPTA1–6.8-D1S484, with
distances in centimorgans (Maestrini et al, 1996). The order of markers and
distances were based on the Ge´ne´thon (Dib et al, 1996) and the CHLC (Murray
et al, 1994) human linkage map.
RESULTS
Thickening of CCE during keratinization was disturbed in the
lesional skin Light microscopically, the biopsy skin sample from an
involved area of the finger of the proband showed marked hyperker-
atosis, slightly thickened granular cell layer, and mild acanthosis without
parakeratosis (Fig 2b). Electron microscopically, basal and spinous cells
in the epidermis did not show significant morphologic abnormalities.
Keratohyalin granules in the thickened granular cell layers appeared
normal (Fig 3a). The transitional cell layer, which is only occasionally
observed in normal skin, was frequently encountered between the
granular and cornified cells. Thin, electron dense cell envelopes were
seen in the superficial granular cells (Fig 3b); however, the increase in
thickness of cell envelopes in the horny layer that always occurs in
normal skin was not observed (Fig 3c). Lipid droplets and remnants
of cellular organelles were present in the cornified cells (Fig 3c). Ring-
shaped structures made up of cell membrane with thin CCE and
desmosomes were frequently observed in the cytoplasm of the upper
granular cells, suggesting phagocytosis or invagination of cell membrane
with abnormally formed CCE into the cytoplasm (Fig 3e). Non-
desmosomal areas of these ring-shaped structures were very sparsely
labeled with loricrin and involucrin antibodies in immunoelectron
microscopy (data not shown).
Defects of loricrin cross-linking were observed in the lesional
skin Immunofluorescence study revealed an abnormal distribution
of loricrin in lesional skin. Membranous loricrin staining was absent in
the granular and cornified cells, and a weak cytoplasmic staining was
observed in the granular cells (Fig 4a). In the uninvolved site of the
patient, loricrin staining was as strong as that in the normal control
skin, and its membranous staining can be seen in the granular and
upper spinous layers (Fig 4b). In normal control skin, loricrin staining
was observed only in the granular layer. In contrast, the expression of
other CCE precursor molecules, involucrin, and SPRP 1 and 2, was
stronger than that in the normal control skin, and their membranous
staining were observed in the upper spinous layer cells as well as
granular cells (Fig 5).
By immunoelectron microscopy, CCE were sparsely labeled with
the loricrin antibody in the patient’s skin (Fig 6a), whereas intense
labeling was seen in normal skin (Fig 6b). In addition, immunoelectron
microscopy revealed that involucrin labels on CCE in patients skin
was rich compared with that in normal skin (Fig 6c, d).
Absence of causative mutations in the entire EDC region of
1q21, including the loricrin gene Direct sequencing of the loricrin
gene of the genomic DNA from the proband (case 1), his affected
sister (case 2), and their parents revealed no mutation in both exons
and exon-intron borders of the loricrin gene. Assuming an autosomal
recessive mode of inheritance, by linkage analysis of three microsatellite
markers spanning in 1q21 (D1S2344, D1S2345, D1S305), using DNA
samples isolated from the proband, his affected sister, and their parents,
the entire EDC region of 1q21 was excluded (Fig 1b).
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DISCUSSION
Loricrin is the major protein component of the CCE (Hohl et al,
1991; Yoneda et al, 1992; Yoneda and Steinert, 1993; Steinert and
Marekov, 1995), transcribed from a single gene within EDC on
chromosome 1q21, where approximately 25 genes involved in epi-
dermal differentiation are known to reside (Backendorf and Hohl,
1992; Volz et al, 1993; Gibbs et al, 1993; Mischke et al, 1996; Marenholz
et al, 1996). Genes in the EDC region are thought to be under the
control of a master regulator, or locus control region, similar to the
globin genes (Townes and Behringer, 1990). In both VS with ichthyosis
and EK, loricrin gene mutations are one bp insertion and result in a
frameshift and delayed termination of transcription (Maestrini et al,
1996; Korge et al, 1997; Ishida-Yamamoto et al, 1997). The wild-type
Figure 4. Weak cytoplasmic expression of loricrin in the granular layers
of the lesional skin. Loricrin immunolabeling is detected by fluorescein
isothiocyanate-conjugated secondary antibody (green) and nuclear stain is
performed by propidium iodide (red). Loricrin immunolabeling in the lesional
skin (a) and nonlesional skin (b) of the patient. Immunofluorescent labeling of
loricrin is abnormally weak, cytoplasmic in the granular layers of the lesional
skin in contrast to linear membranous stainings in the nonlesional site. Scale
bars, 50 µm.
Figure 5. Membranous stainings in the
granular and upper spinous layers both
for involucrin and for SPRP 1 and 2
are similarly observed in lesional and
nonlesional skin of the patient. Involucrin
and SPRP 1 and 2 immunolabelings are
detected by fluorescein isothiocyanate-
conjugated secondary antibody (green) and
nuclear stain is carried out by propidium
iodide (red). Involucrin immunolabeling in
lesional skin (a) and nonlesional skin (b),
SPRP 1 and 2 immunolocalization in lesional
skin (c) and nonlesional skin (d) of the patient
and normal control skin (e). Scale bars, 50 µm.
Figure 6. Post-embedding immuno-
electron microscopy shows strikingly
reduced loricrin deposition to CCE in
lesional skin. Ultrastructural distribution of
loricrin and involucrin is demonstrated by
silver-enhanced immunogold particles. Note
sparse loricrin labeling on CCE of a cornified
cell in the patient skin (a), in contrast to dense
loricrin labeling in normal control skin (b).
On the other hand, involucrin labeling on
CCE of a cornified cell is rich in the patient
skin (c), but not in normal control skin (d).
Scale bars, 0.2 µm.
loricrin polypeptide is 315 amino acids in length (Yoneda et al, 1992),
and these mutations replace the carboxy-terminal one-third of loricrin
with missense amino acids, obliterating approximately one-third of the
glutamine and lysine residues involved in transglutaminase-mediated
cross-link formation. These highly deleterious mutations are speculated
to impair the function of loricrin in a dominant-negative manner, by
diminishing its flexibility (Steinert et al, 1991) and by impairing its
ability to cross-link to itself and to other cornified envelope components
(Maestrini et al, 1996; Korge et al, 1997; Ishida-Yamamoto et al, 1997).
Vohwinkel’s syndrome shows palmoplantar hyperkeratosis with a
honeycomb appearance, pseudoainhum, and ichthyotic lesions on other
body sites (Vohwinkel, 1929; Gibbs and Frank, 1966; Camisa and
Rossana, 1984; Camisa et al, 1988), whereas progressive symmetric
EK, or simply EK, is a rare inherited disorder of epidermal cornification
characterized by erythematous hyperkeratotic plaques (Hopsu-Havu
and Peltonen, 1970). These nonmigratory, erythematous plaques
develop shortly after birth, and are distributed symmetrically over the
body, particularly on the extremities, hands, feet, the buttocks, and
sometimes the face, together with PPK (Nir and Tanzer, 1978; Levi
et al, 1982; Maldonado-Ruiz et al, 1982; Nazzaro and Blanchet-
Bardon, 1986; Lamprecht et al, 1988; Kudsi and Naeyaert, 1990;
MacFarlane et al, 1991; Kiesewetter et al, 1993; Niemi and Kanerva,
1993; Gray et al, 1996). Our cases clinically showed PPK with
mutilation of fingers that is similar to that seen in VS and EK; however,
they lack the honeycomb appearance of hyperkeratosis, deafness,
symmetrical erythematous plaques on the body, and apparent family
history of dominant inheritance. This family as well as VS and EK
belong to a group of MPPK that consist of several other cornification
disorders including Mal de Meleda, keratosis palmoplantaris striata,
pityriasis rubra pilaris, congenital ectodermal defect, pachyonychia
congenita, etc. (Gibbs and Frank, 1966).
Defective loricrin deposition in our family was similar to that of
reported cases of VS and EK with loricrin gene mutations (Maestrini
et al, 1996; Korge et al, 1997; Ishida-Yamamoto et al, 1997). These
similarities suggested an involvement of loricrin abnormality in our
case, too; however, in cases of VS with loricrin gene mutation,
abnormal loricrin distribution was reported even in nonlesional sites
(Korge et al, 1997). To the contrary, membranous loricrin staining in
the nonlesional skin of the patient was as strong as that seen in normal
control skin. In addition, intranuclear loricrin granules in the granular
cells and the parakeratotic cornified cells, which were seen in VS and
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EK with loricrin gene mutations (Maestrini et al, 1996; Korge et al,
1997; Ishida-Yamamoto et al, 1997), were not observed in our case.
These results indicated that defective loricrin cross-linking is restricted
to the lesional skin in our case and that the loricrin abnormality might
be a secondary event. Furthermore, direct sequence analysis of the
loricrin gene failed to detect any mutations in this family. Assuming
an autosomal recessive mode of inheritance, linkage analysis excluded
the possibility that the causative mutation is localized in the EDC
region of 1q21 coding not only loricrin, but also SPRP, involucrin,
trichohyalin, etc. (Backendorf and Hohl, 1992; Volz et al, 1993; Gibbs
et al, 1993; Mischke et al, 1996; Marenholz et al, 1996). These data
confirmed that a causative defect in this family is not in the loricrin
or other EDC genes/molecules.
According to the consanguinity of the family and the absence of
other affected members in the generations other than the proband and
his sister, we can predict recessive inheritance of MPPK in this family.
One can assume that the defect of loricrin cross-linking in this family
is not due to a dominant negative effect reported in VS and EK with
loricrin mutation (Maestrini et al, 1996; Korge et al, 1997; Ishida-
Yamamoto et al, 1997), but by a total absence or defect of a key
molecule for loricrin cross-linking. Loricrin cross-linking is thought to
occur at the late stage of CCE formation (Steven et al, 1990; Bickenbach
et al, 1995; Ishida-Yamamoto et al, 1996) and an unknown abnormality
that can affect the final step of CCE formation is now suspected as the
causative factor in this family.
In a family of VS without ichthyosis, a causative mutation outside
the EDC region was suggested (Korge et al, 1997). It should be
emphasized that the cases reported in this study are the first non-VS
MPPK family in which mutations in the entire EDC region were
excluded. Even if it is a secondary phenomenon, abnormal loricrin
cross-linking may be a common event in several types of PPK with
mutilation, including some families of VS, EK, and MPPK with or
without loricrin gene abnormalities. Future investigations should serve
to further define the molecular basis of each clinical phenotype
of MPPK.
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